Sign in to continue:

Wednesday, March 4th, 2026

Beijing Luzhu Biotechnology Announces Board Meeting to Approve 2025 Annual Results and Final Dividend

Key Points for Investors

  • Date of Board Meeting: March 18, 2026. This is when major decisions regarding annual performance and dividend payouts will be made.
  • Annual Results Announcement: The Group’s financial performance for the entire year of 2025 will be reviewed and approved, which could have a direct impact on the company’s stock valuation.
  • Final Dividend Proposal: The Board will consider the declaration of the final dividend. Any dividend announcement can be price-sensitive and may influence the share price, depending on the payout ratio and overall financial health.

Details for Shareholders

The upcoming board meeting is a critical event for shareholders of Beijing Luzhu Biotechnology. Historically, the approval of annual results and the declaration of dividends are closely watched by the market. The confirmation of positive earnings or an attractive dividend payout can act as a catalyst for share price appreciation. Conversely, any indication of weaker-than-expected results or the absence of a dividend may lead to negative sentiment.

Investors should stay alert to the outcome of this meeting, as the results and any dividend declaration are likely to be price-sensitive and could significantly impact the valuation of the company’s shares.

Board Composition

As of the date of the announcement, the Board comprises:

  • Executive Directors: Mr. KONG Jian (Chairman), Ms. PENG Ling, Ms. ZHANG Yanping
  • Non-executive Directors: Mr. MA Biao, Mr. KONG Shuangquan
  • Independent Non-executive Directors: Ms. HOU Aijun, Mr. LEUNG Wai Yip, Mr. LIANG Yeshi

This diverse Board is responsible for overseeing the Group’s strategic direction and ensuring robust corporate governance.

What to Watch For

  • Investors should monitor the outcome of the March 18, 2026 meeting closely, as both the annual financial results and any dividend announcement are likely to be price-sensitive. These factors could drive significant movement in Beijing Luzhu Biotechnology’s share price.
  • Any deviation from expectations—either positive or negative—regarding earnings or dividends could influence market sentiment and trading activity.

Disclaimer: This article is prepared for informational purposes only and does not constitute investment advice. Investors should conduct their own research and consult with licensed financial advisors before making investment decisions. The company’s announcements and financial performance are subject to change and may impact share prices.

View LUZHU BIOTECH-B Historical chart here



Disclosure of Share Dealings in ENN Natural Gas Co., Ltd. by Morgan Stanley Bank, N.A. on 27 February 2026

Disclosure of Dealings in ENN Natural Gas Co., Ltd. Shares by Morgan Stanley Bank, N.A. Key Disclosure: Dealings in ENN Natural Gas Co., Ltd. Shares by Morgan Stanley Bank, N.A. Date of Disclosure: 2...

ENN Energy Holdings Limited Share Dealings Disclosure by Morgan Stanley – February 2026

Significant Share Dealing Disclosure: ENN Energy Holdings Limited – Potential Price Impact Significant Share Dealing Disclosure for ENN Energy Holdings Limited Date: 25 February 2026 Event: Public Disclosure of Dealings in Shares – Privatisation...

Disclosure of Morgan Stanley Dealings in ENN Energy Holdings Shares During Privatisation Scheme (March 2026)

Morgan Stanley Securities Dealings in ENN Energy Holdings Amid Privatisation Scheme Morgan Stanley Discloses Significant Derivatives Dealings in ENN Energy Holdings During Privatisation Scheme Key Highlights Privatisation Context: The report details derivatives transactions by...

   Ad